Testing effectiveness (Phase 2)Study completedNCT00971620
What this trial is testing
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
Who this might be right for
Cutaneous LeiomyomasHereditary Leiomyomatosis and Renal Cell Cancer
National Cancer Institute (NCI) 18